Matrix regenerative therapy
C. Timaru, Cornel Ştefan, D. Iliescu, Algerino De Simone, M. Batras
2017Romanian Journal of Ophthalmology
Paper details
- Journal
- Romanian Journal of Ophthalmology
- Published
- 2017
- Citations
- 12
- References
- 21
- Fields
- Materials Science, Medicine, Chemistry
tlooto Summary
Regenerating agents (RGTA®) are bioengineered structural analogues of heparan sulfate glycosaminoglycans that replace the degraded endogenous HS of the ECM that plays a role in controlling and regulating the wound healing process in various ocular diseases.
Abstract
The extracellular matrix (ECM) is responsible for many of the cell behavior processes, including cell proliferation and growth, survival, change in cell shape, migration, and differentiation. The most important component of the ECM is heparan sulfate (HS), because it insures the storage of many cell communication proteins, necessary for the continuous and identical renewal of cells and thus for tissue regeneration. Regenerating agents (RGTA®) are bioengineered structural analogues of heparan sulfate glycosaminoglycans that replace the degraded endogenous HS of the ECM. In the ophthalmological field, RGTA® represents an innovative approach for the improvement of the ocular surface wound healing and matrix remodeling and plays a role in controlling and regulating the wound healing process in various ocular diseases.
Citation format
TIMARU, C., et al. Matrix regenerative therapy. Romanian Journal of Ophthalmology, 2017, 61(1): 2–10.